Thursday, October 6, 2022
News
NEWS HOME
PRN INDIA
BAL Pharma Limited announces Q1FY23 results
  SocialTwist Tell-a-Friend  
   

  • Formulation Business witnesses robust growth of 50% YoY
  • Export Formulation grows by 69.43% YoY to 307.71 million in Q1FY23

BENGALURU, India, Aug. 15, 2022 /PRNewswire/ -- BAL Pharma Limited, a fully integrated pharmaceuticals Company specialising in Bulk Drugs, Prescription Drugs, Generics, and pharma intermediates has announced its results for the Quarter ended 30th June 2022.

Financial Highlights (Standalone) – Q1FY23

Particulars (₹ Mn)

Q1FY23

Q1FY22

YoY

FY22

Revenue

700.71

711.38

-1.50 %

2,868.56

EBITDA

60.05

76.23

-21.23 %

296.92

PBT

18.06

29.59

-38.97 %

120.56

PAT

14.07

21.48

-34.50 %

85.73

EPS

0.95

1.45

-34.48 %

5.67

Financial Highlights

  • Revenue – The Company reported revenue of ₹ 700.71 million for Q1FY23 as compared to ₹ 711.38 million for Q1FY22. Revenue was impacted by macro and uncontrolled factors led by geopolitical concerns, external market turmoil and certain other unavoidable market factors. Such scenarios led to tighter inventory management and unavoidable price disruption which the company resisted to certain extent by focussing on other markets and also focussed on other formulations as well
  • EBITDA – EBITDA for Q1FY23 stood at ₹ 60.05 million as compared to ₹ 76.23 million for Q1FY22. Margins were impacted by lower Price realisations from API products, along with severe raw material prices increase. Global commodity inflation led to increase in various intermediate prices which impacted raw material costs. The Company has been attempting to lower the impact by adapting various raw material procurement strategies. The company has been strategizing alternate sources for its raw material procurement. This shall not only stabilize the cost but also create a long-term sustainable approach in its overall strategy
  • PAT: PAT for Q1FY23 stood at ₹14.07 million as compared to ₹21.48 million for Q1FY22.
  • Formulation Business: The formulation business remained the revenue growth driver and witnessed robust growth of 50% whereas export formulation grew by 69.43% and stood at ₹307.71 million for Q1FY23 as compared to ₹181.62 million for Q1FY22. Domestic formulation grew by 2.96% and stood at ₹77.66 million for Q1FY23 as compared to ₹75.43 million for Q1FY22.
  • API Business: API business revenue stood at ₹303.49 million for Q1FY23 as compared to ₹446.1 million for Q1FY22.

Formulations Business(FDF) - the revenue growth driver

  • Formulations segment revenue stood at ₹385.37 million in Q1FY23 as compared to ₹257.05 million in Q1FY22.
  • Exports to Domestic was at 71:29 in Q1FY23 versus 80:20 in Q1FY23.
  • The share of formulations in total revenue increased to 56% in Q1FY23 from 37% in Q1FY22. Formulation exports witnessed a robust growth of 69.43% YoY for Q1FY23.
  • The company has setup A phytoceutical division for its herbal line products which caters to the niche category of consumers who prefer natural and herbal products for their lifestyle
  • The order book for formulation stands at ₹270 million as on Q1FY23.

API Business – an integrated business model

  • API segment revenue stood at ₹303.49 million in Q1FY23 as compared to ₹446.1 million in Q1FY22.
  • The share of API in total revenue is 44% in Q1FY23 as compared to 63% in Q1FY22.
  • Exports: Domestic mix was 70:30 in Q1FY22 versus 58:42 in Q1FY23.
  • The total Order book for APIs remains strong at ₹370 million as on Q1FY23. APIs such as Alfuzosin for prostate enlargement, and Dabigatran for cardiac care are under scale-up. Along with these APIs, Total of 8 products are under development and scale-up.

Operational Highlights

Expanding into new Geographies- BAL Pharma is expanding its footprints into new geographies in both segments. In API, they have expanded their presence in Uzbekistan, Guatemala, and Malta. This geographical expansion will add more value to the business and ultimately enhance profitability in the coming years.

New Customers- Backed by a strong medical representative and marketing team, BAL Pharma is constantly adding new customers from various geography and enhancing the customer base. They have added nine customers in the API segment and two customers in the exports formulations segment. They are constantly strengthening their customer base which is an indication of their efforts and commitment to the business. The customer base assures the business sustainability & profitability and provides a positive long-term outlook about the business.

Enriched product pipeline- The Company has a strong product pipeline and robust order book in both API and Product segments. Backed by a strong pipeline, the company's overall business outlook looks positive and promising. Company product pipeline in API is ₹370 million and Formulations is ₹270 million.

Future Readiness- There is tremendous growth opportunity in the pharmaceuticals industry. The Government is extending enormous support to pharmaceutical companies by launching the PLI scheme. Bal Pharma is a beneficiary of this PLI scheme. The Company expects an average annual turnover of INR 1,250 million p.a from the eligible products in the next 5 to 6 years. BAL Pharma is strengthening and preparing themselves under all the parameters to cater to the maximum market opportunity and market share. They have more than two decades of experience, five manufacturing facilities, 200+ finished products, 80+ presence across the countries, 370 tonnes API capacity, 22+ API molecules and 1000+ employee strength. Additionally, they have hired seasoned professionals, are strengthening the marketing team, and deploying the required CAPEX in offices and units. All these long and short-term initiatives will collectively contribute and enable them to cater to the maximum available market opportunity.

Commenting on financial results, Mr. Shailesh Siroya, Managing Director, BAL Pharma said, "Despite several challenges in the marketplace - both on the demand and the supply side, we turned out a resilient set of numbers for Q1FY23. We had to navigate through a volatile market, inflated raw material procurement costs, and steep fuel and freight charges. We also made investments in hiring highly qualified professionals to support our ambitions. I expect them to take our operational excellence to a different level and bolster our journey towards quality growth. On the positive side, the Company has a robust product pipeline, and is strategically improving its presence in both domestic and international markets. In particular, our formulations business is gaining solid momentum by growing 50% YoY – which should help improve our margins profile continually. Recently, we have expanded into three new geographies and added strategic new customers that will bode well for us in the long term. Government support in the form of PLI scheme will further boost our overall growth strategy. Going forward, we foresee strong demand growth for our various products, and we are placing concerted efforts for improving our profitability in the coming quarters."

About BAL Pharma Ltd (BPL)

Bal Pharma Limited (BSE: 524824) (NSE: BALPHARMA) is a fully integrated pharmaceuticals Company specialising in Bulk Actives, Prescription Drugs, Generics and pharma intermediates. Bal Pharma's focused therapeutic areas are Anti-diabetes, Anti-histamine, Anti-inflammatory, Acne Treatment, Gastroenterology, Cardiology, and dermatology. The Company is one of the largest producers and exporters of Gliclazide, a medicine to treat type-2 diabetes. Bal Pharma's niche APIs and FDFs are produced at world-class manufacturing facilities located in Karnataka, Maharashtra, Rajasthan and Uttarakhand. The Company exports APIs to Europe, Australia, Japan, the Far East, Canada, Latin America, Africa, the Middle East and other World markets. Its FDFs are exported to a Semi-regulated market, besides having a domestic presence. Backed by strength in Research and Development, and strong infrastructure, Bal Pharma is poised to become a significant Company in the pharmaceutical industry.

Forward-Looking Statement:

Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. BAL Pharma Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances

More News by PR Newswire India

World Agricultural Center Opens in Harbin, China

ICANN Board Elects New Leadership

Archer Aviation Applauded by Frost & Sullivan for Enabling Easier Intercity Travel with Its Urban Air Mobility Solutions

Titan.ium Platform's Portfolio Provides a Value-Added Customer Defined Applications (CDA) Product Suite

HABANOS, S.A. PRESENTED QUAI D'ORSAY IMPERIALES TRAVEL HUMIDOR AT THE TFWA INTERNATIONAL FAIR IN CANNES

New Torch and Grit Test Method by UL Solutions Offers a Standardized Approach to Screen Electric Vehicle Battery Enclosure Materials

Sumsub launches 1-click - document-free verification for over 2 billion users

Navisite Expands 'Next Steminist' Scholarship Program to India

IGU 2022 Global Wholesale Gas Price Survey Report

Survey commissioned by IHG Hotels & Resorts reveals what consumers value when they travel

lowRISC Appoints Cybersecurity Expert Prof. Dr. Claudia Eckert to Board of Directors

Brazilian Connected Trucks Telematics will Reach 2.59 Million Units by 2027

JACK&JONES, VERO MODA & ONLY launch their newly re-vamped flagship store on Linking Road, Mumbai

Cancer Can Be Treated! OncoDynamiX Launches Cancer treatment solutions to South Asia, Africa, and Latin American countries

Teachers Have the Power to Transform Lives

AG&P Group Appoints Sandeep Mahawar as Chief Commercial Officer of LNG Terminals and Logistics

Tejas Networks wins "Best Made in India Telecom Innovation award" at India Mobile Congress (IMC)

Bloom IVF Group rolls out Artificial Intelligence across its clinics in India, helping patients get pregnant sooner and for lower cost

INFANTINO AND BECKHAM HAIL ASPIRE ACADEMY AS INTEGRAL TO QATAR'S WORLD CUP LEGACY AS GLOBAL SUMMIT 2022 ENDS

Celigo Opens APAC Headquarters Amid Record Growth in Region

PARADISO, BARCELONA IS NO.1 AS THE WORLD'S 50 BEST BARS 2022 ARE REVEALED

infodas receives NITES certification from the Cyber Security Agency of Singapore

Automation Anywhere and the Center for Humanitarian Technology Launch 'Telegram for Humanity' Bot to Aid Refugees in Ukraine

Pomerantz Law Firm Opens London Office

Sphera Completes Previously Announced Acquisition of riskmethods, a Leader in Artificial Intelligence Supply Chain Risk Management Software

Hard Rock International Celebrates 23rd Annual PINKTOBER Campaign by Partnering with World-Renowned Chef Dominique Crenn

World's Fastest Growing Staking Service Provider Born out of Lugano, Switzerland

Firmenich Annual General Meeting 2022

Unispace: Data reveals Gen Z rely on the traditional office more than any other generation

Information Office of Beijing Municipal Government' Features: "My Beijing, My Story" Depicts the Lifestyle of People Living in Beijing

Automation Anywhere Unveils the Automation Success Platform with a Surge of Innovations

Deloitte Named a Leader in Worldwide Industry Cloud Professional Services by the IDC MarketScape

HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK

Solace Launches Event Portal 2.0, Addressing the Biggest Challenges Enterprises Face in Designing, Managing and Governing Event-Driven Architecture at Scale

IMG Appoints Amanda Winkle as Chief Operating Officer

Vinco Ventures Announces Ross Miller as CEO and Settlement of Litigation

RevitaLash® Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement

Aspire Academy and FIFA Kick Off the 8th Global Summit with high profile FIFA guests David Beckham and Wenger

EvolveWare Facilitates Non-disruptive Application Modernization with Industry's First and Only Agile Business Rules Extraction Solution

Stamus Networks Signs Reseller Agreement with EliteVAD

China Matters' Feature: How Does Basketball Shape Dongguan's Sports Culture?

Altair Presents Open, Flexible, and Scalable Total Digital Twin Solution

IZUMA NETWORKS ACQUIRES PELION'S DEVICE MANAGEMENT BUSINESS

Globalization Partners Rebrands as G-P and Reaffirms its Promise to Make a Global Workforce Possible for Growing Companies

Secureworks State of the Threat Report 2022: 52% of ransomware incidents over the past year started with compromise of unpatched remote services

First-of-its-kind government-industry partnership announced between Deakin University, Australia and Ministry of Education and Ministry of Skill Development and Entrepreneurship, Government of India

LyondellBasell Catalyst Production Expansion Adds Life to Infrastructure Projects

BE EVERYTHING - A new chapter opens in the story of United Colors of Benetton: new creative director, Andrea Incontri presents his first fashion show

PwC announces record global revenues of US$50 billion

Challenge the Highest Level of <MIR4>! A New Content, Hell Raid, Unveiled

Leading Gaming technology provider Quixant announces the launch of new cabinet offering

StoreHippo® launches Mystore Buyer and Seller Apps for ONDC

Cambrex Announces Stability Storage Expansions in Ireland and Belgium

TimesPro collaborates with IMT Hyderabad to launch programmes in Business & Retail Management

Industrial Transformation ASIA-PACIFIC 2022 returns to catalyse sustainable growth for advanced manufacturing in the region

The PI Group and Averna Announce their Partnership

Academic partnerships in focus, Global Education Summit commences at Chandigarh University

UST and Mendix Collaborate to Accelerate Low Code Development in Spain

Nestlé launches NESCAFÉ Plan 2030 to help drive regenerative agriculture, reduce greenhouse gas emissions and improve farmers' livelihoods

Ingenico Launches as Independent Company Following Acquisition by Apollo Private Equity Funds

Stockify announces single-window online service to buy unlisted equities

Manipal Hospital Whitefield's Exclusive Take on Minimally Invasive Advanced Surgical Procedures (MIAS)

THE LEELA PALACES, HOTELS AND RESORTS PARTNERS WITH RAJASTHAN POLO CLUB FOR ITS INAUGURAL SPONSORSHIP OF THE ROYAL SPORT IN INDIA

CLO Virtual Fashion Announces the Acquisition of GoVise Technologies

Education Cannot Wait Announces US$11.8 Million Catalytic Grant in Haiti

DXC Technology Calls for Latest Innovations from Insurance Startups and Scaleups across Asia Pacific through the DXC Invitational

Global AdTech Company TripleLift Names Dave Clark as New Chief Executive Officer

Navneeth Sulakhe joins Innoviti as Senior VP Human Resource Management

KEI Wires & Cables Hosts Real Kabbadi League Season 2

Automation Anywhere Secures $200 Million in Financing from Silicon Valley Bank and Hercules Capital

2022 World Trade Centers Association Member Forum Returns to New York City for First Time in Two Years

TATA POWER REINFORCES COMMITMENT TOWARDS GREEN ECOSYSTEM CONSERVATION ACROSS ITS RENEWABLE SITES

Azure Power wins the prestigious Golden Peacock Award for Sustainability

FANDOM ACQUIRES LEADING ENTERTAINMENT & GAMING BRANDS INCLUDING GAMESPOT, TV GUIDE AND METACRITIC

National Engineering Industries Ltd (NBC Bearings) honored with 'Iconic Brands of India 2022'

Celebrating Glorious 35 Years of BIMTECH

HABANOS, S.A. PRESENTED THE MONTECRISTO WIDE EDMUNDO IN WORLD PREMIERE IN SPAIN

Sanjay Ghodawat Foundation awarded The Mahatma Award 2022

STL announces Gram Galaxy - India's first integrated solution to connect villages with fibre

DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY

Healthium Medtech amongst the first in Asia and first Indian Medtech Company to receive CE certification under the EU MDR (European Union Medical Device Regulation) norms for Class III implants

Jagadguru Kripalu Parishat holds Grand Rath Yatra on 3rd October 2022 near Kunda, Pratapgarh in honor of the 100th Birth Anniversary of Jagadguru Shri Kripalu Ji Maharaj

Addteq APAC Announces Rebranding, Changes Name to Enreap

Karwa Chauth 2022: FlowerAura Is All Geared Up To Enhance The Celebrations

DMCC AWARDED GLOBAL FREE ZONE OF THE YEAR FOR EIGHTH CONSECUTIVE YEAR

New Book Property Tax in Asia Provides the First Comprehensive Analysis of the Property Tax Across the World's Largest Continent

UN WOMEN'S HeForShe EXPANDS MOVEMENT THROUGH KEY PUBLIC AND PRIVATE PARTNERSHIPS IN EAST ASIA

STL unveils 5G cosmos to help Indian telcos fiberise their networks for 5G

STL launches Multiverse - India's first Multicore fibre and cable; aims to revolutionize the optical landscape

Tejas Networks successfully demonstrates end-to-end network based on its indigenous 4G/5G wireless, optical and satellite products

IIIT Hyderabad and Silicon Labs Launch Campus-wide Wi-SUN Network for Smart City Applications

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Assam: BJP cadres miffed with reports of...
Organiser of Durga Puja where Mahishasur...
Fake job racket: MEA rescued 45 trapped ...
One pilot killed, another injured as Arm...
7 dead, several feared missed after flas...
CBI gets active for third time in Vijaya...
More...    
 
 Top Stories
OPEC announces big cut in oil produ... 
National Games: Boxers Lovlina, Jai... 
Pakistan government to call out arm... 
Organiser of Durga Puja where Mahis... 
KCR's national party to start expan... 
Over 5 lakh people witness historic... 
How a bot makes the lives of Ukrain... 
Man in custody in connection with I...